Therapy News and Research

RSS

AIDS 2010 calls for extension of human rights protections as central tenet of global response to AIDS

The appalling lack of access to scientifically proven interventions for key populations at risk -- including sex workers, men who have sex with men and people who use drugs - and the lagging scale up of simple and inexpensive treatment regimens to prevent vertical transmission of HIV reflect persistent, underlying human rights violations that threaten future progress on AIDS, according to organizers of the XVIII International AIDS Conference taking place in Vienna this week under the theme of Rights Here, Right Now.

23 Jul 2010

Emotional barriers, structural barriers can prevent PLWHA from seeking care, treatment: Survey

Bristol-Myers Squibb Company today presented results from a national survey which found that emotional barriers, such as stigma, fear, denial and shame, and structural barriers, such as lack of knowledge, transportation, and insurance coverage, can prevent people living with HIV/AIDS from seeking care and treatment.

23 Jul 2010

New biophotonic imaging method monitors transformations of cellular macromolecules during apoptosis in real-time

Apoptosis, programmed cell death, is essential to normal development, healthy immune system function, and cancer prevention. The process dramatically transforms cellular structures but the limitations of conventional microscopy methods have kept much about this structural reorganization a mystery.

23 Jul 2010

Research on new treatments for FXS to be presented at International Fragile X Conference

Accelerated research findings leading to potentially significant new treatments for fragile X syndrome will be presented to nearly 1,000 family members and professionals at the 12th International Fragile X Conference in Dearborn July 21-25.

23 Jul 2010

New model for scaling up treatment, prevention of HIV amongst IDUs

Against the backdrop of some of the globe's fastest growing HIV epidemics in Eastern Europe and Central Asia, a report launched today at the XVIII International AIDS conference in Vienna makes the case for a new model for scaling up treatment and prevention of HIV amongst Injecting Drug Users.

23 Jul 2010

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Nevada Cancer Institute (NVCI) is launching its Plus One Program, a paid nursing internship initiative to equip nursing graduates with advanced training to give them an edge in today's competitive nursing job market. After completing a paid one-year internship at NVCI, participants will become oncology nurses, a highly sought-after specialty. These specialized jobs have the potential to pay increased wages, provide excellent benefits and support articulated career ladders within the field of oncology.

23 Jul 2010

Circulating aberrant cells increase as non-small cell lung cancer progresses

A novel approach detects genetically abnormal cells in the blood of non-small cell lung cancer patients that match abnormalities found in tumor cells and increase in number with the severity of the disease, a research team led by scientists at The University of Texas MD Anderson Cancer Center report in the journal Clinical Cancer Research.

23 Jul 2010

Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard.

23 Jul 2010

African Americans at increased risk of kidney failure caused by hypertension

Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.Earlier studies showed patients of all races with Chronic Kidney Disease were at greater risk of dying prematurely from cardiovascular disease than reaching ESRD.

23 Jul 2010

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

New data were presented today at the 18th International AIDS Conference from the VERxVE study that show an investigational, once-daily extended-release (400 mg QD) formulation of nevirapine was non-inferior to twice-daily immediate release Viramune® (nevirapine) tablets (200 mg BID), both in combination with Truvada® (tenofovir and emtricitabine) tablets in treatment-naive HIV-1 infected patients through 48 weeks.

23 Jul 2010

Effective prevention therapy, early critical care and rehabilitation needed to overcome cost burden of stroke

The consequences of stroke, reported to be the third leading cause of death in the U.S., can extend beyond the physical to impose devastating financial burdens on families and society in general. According to the American Heart Association, the total direct and indirect costs of stroke in 2008 have been estimated at $65.5 billion.

23 Jul 2010

Chronic facial pain may be symptom of temporomandibular joint disorder

Do you suffer from chronic facial pain, including constant pain in or around your ears, sore jaw, ringing in your ears, clicking or popping sounds when you open or close your mouth or chronic headaches and neck pain? Do you often feel like your jaw is stuck open or closed? Do you feel as though you have a limited opening of your mouth?

23 Jul 2010

NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short bowel syndrome

NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today announced the completion of patient randomization in its Phase 3 registration study of GATTEX® (teduglutide). The double-blind, placebo-controlled safety and efficacy study, which is known as STEPS, is being conducted in patients with parenteral nutrition (PN) dependent short bowel syndrome (SBS) and is now fully randomized with 86 patients.

23 Jul 2010

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that a 44-year-old female patient with advanced acute promyelocytic leukemia (APL) achieved molecular complete remission with no evidence of disease in the blood cells and/or bone marrow following treatment with CytRx's oncology drug candidate tamibarotene.

23 Jul 2010

Major breakthrough in Alzheimer's disease research

Researchers from the University of Sydney's Alzheimer's and Parkinson's Disease Laboratory have achieved a major breakthrough by finding the causes of Alzheimer's disease at a cellular level and thereby identifying a potential therapy as a result.

23 Jul 2010

Endologix second-quarter total revenue increases 19% to $15.7 million

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2010.

23 Jul 2010

New HIV drug on the block

Johnson and Johnson’s experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.

22 Jul 2010

Three toxins in food identified as triggers to gluten intolerance: study

Coeliac disease cause by intolerance to gluten present in food and drinks like bread, pasta, cereals, biscuits and beer commonly affects many people all over the world. This affects 1 percent of all people in UK, especially women. Patients are advised to stay away from gluten to prevent damage to their intestines. In spite of this in five years most patients develop problems in their intestines. A gluten free diet is also difficult to maintain. Possible symptoms include diarrhoea, nausea and vomiting, recurrent stomach pain, tiredness, headaches, weight loss and mouth ulcers. These may be mild, moderate or severe in different individuals.

22 Jul 2010

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

Bristol-Myers Squibb Company today reported results for the second quarter of 2010 which featured data on key marketed and investigational compounds in its oncology, diabetes and cardiovascular franchises, and growth in sales and EPS. The company also confirmed guidance for 2010 and minimum guidance for non-GAAP EPS in 2013.

22 Jul 2010

MedeAnalytics, Health Net enter agreement to provide healthcare performance management solutions

MedeAnalytics, a leading provider of healthcare performance management solutions, announced that it has entered into a multi-year agreement with Health Net, Inc. to provide performance management solutions for Health Net's health plan operations and Medicare products. The solutions will enhance Health Net's current data analytics capabilities and include Medical Management Analytics, Provider Network Management Analytics and Operations Performance Management.

22 Jul 2010

Therapy News and Research

AIDS 2010 calls for extension of human rights protections as central tenet of global response to AIDS

Emotional barriers, structural barriers can prevent PLWHA from seeking care, treatment: Survey

New biophotonic imaging method monitors transformations of cellular macromolecules during apoptosis in real-time

Research on new treatments for FXS to be presented at International Fragile X Conference

New model for scaling up treatment, prevention of HIV amongst IDUs

NVCI, CSN and Workforce CONNECTIONS partner to launch ARRA funded nursing internship program

Circulating aberrant cells increase as non-small cell lung cancer progresses

Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study

African Americans at increased risk of kidney failure caused by hypertension

Boehringer Ingelheim's VERxVE study of nevirapine meets primary endpoint

Effective prevention therapy, early critical care and rehabilitation needed to overcome cost burden of stroke

Chronic facial pain may be symptom of temporomandibular joint disorder

NPS completes patient randomization in GATTEX Phase 3 study for PN dependent short bowel syndrome

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Major breakthrough in Alzheimer's disease research

Endologix second-quarter total revenue increases 19% to $15.7 million

New HIV drug on the block

Three toxins in food identified as triggers to gluten intolerance: study

Bristol-Myers Squibb second-quarter net sales increase 2% to $4.8 billion

MedeAnalytics, Health Net enter agreement to provide healthcare performance management solutions

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News